{"preliminary_commentary":{"by_channel":{"x_thread":3},"note":"Preliminary. Indexed podcasts, YouTube videos and X posts that name this trial so far. A report screens them, searches for more and cites what clinicians said when it is built, so final coverage is set at build."},"free_build":{"available":false},"name":"NCT06492005","nct_id":"NCT06492005","offer":{"currency":"USD","how":"Order at https://www.erudio.com/contact?report=nct06492005. The price is an estimate of verified statements from the commentary indexed so far, fixed at order. Final coverage is set when the report is built. We build the report within 24 hours of confirming the order and deliver it when it passes our checks; if it cannot be built to our standard, nothing is charged.","price_usd":750,"size":"focused","size_rule":"Focused: 1–150 verified statements, estimated at 14 per indexed commentary source"},"registry":{"acronym":null,"arms":[{"description":"Drug：9MW2821","label":"Treatment Cohort A:9MW2821","type":"EXPERIMENTAL"},{"description":"Drug: 9MW2821,PD-1 inhibitior","label":"Treatment Cohort B:9MW2821+PD-1 inhibitior","type":"EXPERIMENTAL"},{"description":"Drug: 9MW2821,PD-1 inhibitior","label":"Treatment Cohort C:9MW2821 ±PD-1 inhibitior","type":"EXPERIMENTAL"}],"collaborators":[],"completion_date":{"date":"2027-07","type":"ESTIMATED"},"conditions":["Triple-Negative Breast Cancer"],"enrollment":{"count":160,"type":"ESTIMATED"},"has_results":false,"interventions":[{"name":"9MW2821","otherNames":[],"type":"DRUG"},{"name":"PD-1 inhibitior","otherNames":[],"type":"DRUG"}],"last_update":"2025-01-10","lead_sponsor":"Mabwell (Shanghai) Bioscience Co., Ltd.","official_title":"A Phase II Clinical Study of Efficacy and Safety of 9MW2821Monotherapy or Combined With PD-1 Inhibitor in Locally Advanced or Metastatic Triple-Negative Breast Cancer","overall_status":"RECRUITING","phases":["PHASE2"],"primary_completion_date":{"date":"2026-07","type":"ESTIMATED"},"primary_outcomes":[{"measure":"Objective Response Rate","timeFrame":"Up to 24 months"}],"references":[],"start_date":{"date":"2024-07-26","type":"ACTUAL"},"study_type":"INTERVENTIONAL","title":"A Clinical Study of 9MW2821 (and PD-1 Inhibitor) in Locally Advanced or Metastatic Triple-Negative Breast Cancer","url":"https://clinicaltrials.gov/study/NCT06492005"},"report":null,"schema_id":"erudio.trial_listing","schema_version":"3.0","state":"listed","state_text":"No report yet. It can be ordered.","url":"https://www.erudio.com/trials/nct06492005"}